[1] |
CHEN Qun, ZHU Heping, YUAN Xiaolong.
Analysis of 197 cases of pentoxifylline injection and exploring supervision mode of rational drug use in hospitals
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(8): 948-953.
|
[2] |
FAN Jie, JIN Yongming, JIANG Xiaolong, JIANG Guohua.
Molecular mechanism of lncRNA HOTAIR regulating miR-206 on the proliferation and apoptosis of rheumatoid arthritis synovial cells
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(7): 736-742.
|
[3] |
WANG Lin, YU Jianguo, LI Xiao, LUAN Jiajie.
Establish and implement a pre-prescription system for outpatient based on Six Sigma DMAIC model
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(7): 780-787.
|
[4] |
ZHANG Wei, LIU Lei, GUAN Shaoyang, SHENG Zhao, SUN Wenwen.
Analysis of the diagnostic value of fine-needle aspiration cytology and BRAF and RAS gene mutation screening for thyroid cancer
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(6): 653-657.
|
[5] |
WANG Yan, ZHANG Jinhui, ZHAO Yongchen, LIU Hongxiang, LIU Yawei, MIAO Huanhuan, YANG Xincai.
Sequoiaflavone inhibits stem cell properties such as proliferation and invasion of gastric cancer cells by down-regulating PI3K/AKT signaling pathway
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(5): 508-513.
|
[6] |
LIU Tong, XU Jiaming, WANG Jinhuo, YIN Lei, CHEN Yongquan, GUO Jianrong.
Changes of anesthetic drug concentration in plasma during isolation of autologous blood with acute isovolumic hemodilution and its influence on anesthetic effect after reinfusion
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(4): 413-418.
|
[7] |
LI Xinyu, HUANG Xin.
State of clinical application of meloxicam
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(2): 189-197.
|
[8] |
LU Kepeng, LIU Caihong, BI Ying.
Effect of prophylactic anticoagulation duration on venous thrombosis after total hip/knee arthroplasty
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(11): 1269-1274.
|
[9] |
LIU Dan, LIU Ming, JIN Liangyou, PAN Juan, XIN Haoru, LIU Mengyuan, LI Xin, ZHENG Kun, FENG Xiaoling.
Research progress on the antitumor activity of costunolide
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(10): 1168-1176.
|
[10] |
DING Jiamin, WANG Youdi, ZHAO Xiali, JIANG Genfeng, CHEN Siwen, HONG Chengcheng, LI Shuqin, HU Weihua.
Study on the treatment of thin endometrium with growth hormone and vitamin E
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(8): 857-862.
|
[11] |
MA A'xue, LU Xiaohong, DONG Bo, WANG Dong.
Research progress of exosomal miRNA in skin wound healing and regeneration
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(8): 919-924.
|
[12] |
SUI Yuxia, ZHUANG Jie, ZHUANG Min, HUANG Gui.
Delicaflavone inhibits the invasion and migration of gefitinib-resistant lung cancer PC-9/GR cells by regulating epithelial-mesenchymal transition via PI3K/Akt/mTOR pathway
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(6): 614-621.
|
[13] |
DU Wenpeng, AO Jiangen, TAO Yi, WU Guansheng, HE Jiake.
Study on the factors affecting the steady-state blood concentration of tacrolimus in patients with autoimmune diseases
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(6): 645-651.
|
[14] |
WANG Xinli, XU Xiaqing, FANG Hanbing, GUO Yuzhong.
Study of TPA on enhancing the anti-tumor effects of cisplatin and reducing its renal toxicity
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(5): 535-543.
|
[15] |
WU Junchi, YU Nannan, ZHAO Chengcheng, LIU Wenhui, LUO Zhiying, CAI Hualin, LIU Yiping.
Research progress on hydrogen sulfide in tissue repair and regeneration
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(2): 235-240.
|